Jardiance (empagliflozin) reduces heart failure admissions by 30% because it switches on AMPK and switches off mTOR. That interferes with the core biology that causes congestive heart failure. All green box interventions help with that biology. What do you think?
I'm going back to the beginning of your articles in an increased attempt to understand all of this.
Thanks